Clinical trials
Completed Attention Deficit Disorder with Hyperactivity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
587 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 8 |
| 2002 | 6 |
| 2003 | 16 |
| 2004 | 23 |
| 2005 | 32 |
| 2006 | 26 |
| 2007 | 30 |
| 2008 | 32 |
| 2009 | 30 |
| 2010 | 30 |
| 2011 | 19 |
| 2012 | 27 |
| 2013 | 21 |
| 2014 | 40 |
| 2015 | 35 |
| 2016 | 31 |
| 2017 | 31 |
| 2018 | 25 |
| 2019 | 24 |
| 2020 | 14 |
| 2021 | 19 |
| 2022 | 18 |
| 2023 | 17 |
| 2024 | 11 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 587 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 41 |
| Shire | 30 |
| Children's Hospital Medical Center, Cincinnati | 28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 19 |
| Eli Lilly and Company | 17 |
| Supernus Pharmaceuticals, Inc. | 14 |
| Florida International University | 13 |
| New York State Psychiatric Institute | 13 |
| Duke University | 12 |
| NYU Langone Health | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 587 |
| Spasm | 21 |
| Conduct Disorder | 18 |
| Oppositional Defiant Disorder | 18 |
| Autism Spectrum Disorder | 16 |
| Substance-Related Disorders | 14 |
| Attention Deficit and Disruptive Behavior Disorders | 12 |
| Autistic Disorder | 12 |
| Anxiety Disorders | 10 |
| Child Development Disorders, Pervasive | 8 |
Trials
Showing 1 to 25 of 587. Each trial links to its page on Pharma Observatory.
487 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.